NIBEC Co., Ltd. (KOSDAQ:138610)
South Korea · Delayed Price · Currency is KRW 16,690
-300 (-1.77%)
At close: Jul 6, 2026
NIBEC Market Cap
NIBEC has a market cap or net worth of 189.73 billion as of July 7, 2026. Its market cap has decreased by -35.58% in one year.
Market Cap
189.73B
Enterprise Value
175.26B
Revenue
32.34B
Ranking
n/a
PE Ratio
26.00
Stock Price
16,690.00
Market Cap Chart
Since July 13, 2011, NIBEC's market cap has increased from 37.43B to 189.73B, an increase of 406.84%. That is a compound annual growth rate of 11.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 189.73B | -55.53% |
| Dec 30, 2025 | 426.64B | 145.10% |
| Dec 30, 2024 | 174.07B | -20.67% |
| Dec 28, 2023 | 219.42B | 16.28% |
| Dec 29, 2022 | 188.69B | -34.63% |
| Dec 30, 2021 | 288.67B | -32.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 257.71B |
| S.Biomedics | 254.51B |
| curacle co.,ltd. | 245.00B |
| Kanaph Therapeutics | 182.52B |
| Ensol Biosciences | 177.32B |
| Y-Biologics | 172.27B |
| Genome & Company | 169.87B |
| Bio Solution | 152.50B |